A recent parliamentary inquiry has exposed an acute clinical vulnerability at the heart of general practice: hundreds of thousands of severely frail patients are missing out on essential medication safety checks.
The House of Commons Committee of Public Accounts inquiry into Supporting people with frailty outside hospitals revealed that while approximately 226,000 older individuals in England are diagnosed with severe frailty, a mere 16% received a recorded medication review in 2024–25. Furthermore, only 18% received an annual falls risk assessment, and across the wider population aged 65 and over, only 17% were formally assessed for frailty.
With general practice under unprecedented acute consulting pressure, surgeries lack the dedicated clinical hours required to systematically work through complex frailty registers.
Key Takeaways
- The Scrutiny on Primary Care: Parliamentary findings show that 84% of patients diagnosed with severe frailty do not receive an annual medication review, leaving them at severe risk of preventable medication harm and emergency hospitalisation.
- The 30-Minute Reality: Conducting safe, holistic medication reviews for severe multi-morbidity cannot be condensed into routine 10-minute GP appointments; it demands dedicated 30-minute clinical consultations with experienced prescribers.
- Autonomous Pharmacy Capacity: Medacy provides fully managed, CQC-registered clinical pharmacists who absorb deep frailty reviews under internal senior supervision, delivering immediate clinical capacity with zero supervision burden on GP partners.
What Did the PAC Inquiry Say About Frailty Care in General Practice?
The Public Accounts Committee found that primary care teams are falling substantially behind national frailty targets because reactive acute demand prevents practices from carrying out proactive preventative care.
Despite national contractual requirements to identify and manage moderate and severe frailty, the committee established that only 17% of individuals aged 65 and over were formally evaluated using the Electronic Frailty Index (eFI) or clinical assessment tools. More critically, among the 226,000 patients confirmed to live with severe frailty, only 16% had a documented medication review and just 18% had a falls risk assessment recorded.
This clinical deficit is not caused by clinical indifference; it is the structural consequence of a primary care model stretched beyond capacity. Severely frail patients regularly take ten or more medications, suffer from progressive multi-morbidity, and face fluctuating renal and hepatic function. Safely reviewing these regimens requires protected clinical time that GP rotas simply cannot accommodate.
Why Are Severe Frailty Medication Reviews Difficult to Complete in Routine Consultations?
Severe frailty medication reviews are exceptionally difficult to complete within routine practice workflows because deprescribing complex polypharmacy requires an unhurried, multi-layered clinical investigation that exceeds standard appointment lengths.
A comprehensive Structured Medication Review (SMR) for a severely frail patient requires a minimum of 30 minutes of dedicated clinical consultation. During this time, the clinician must:
- Calculate and de-escalate the Anticholinergic Cognitive Burden (ACB) to curb drowsiness, confusion, and catastrophic falls.
- Reconcile blood pathology results, monitoring renal function against narrow therapeutic index medications (such as digoxin, direct oral anticoagulants, and ACE inhibitors).
- Stop preventative medicines that no longer provide symptomatic benefit and carry acute risks of hypotension or delirium.
- Engage in shared decision-making with the patient, their family, or care home teams.
When a surgery is managing dozens of acute on-the-day appointment requests, dedicating 30 uninterrupted minutes per frail patient is virtually impossible. As a result, reviews are either deferred or conducted as administrative box-ticking exercises rather than meaningful therapeutic interventions.
How Does Medacy’s Managed Clinical Pharmacy Model Bridge the Frailty Gap?
Medacy bridges the frailty gap by supplying general practice with directly employed, senior-supervised clinical pharmacists who take end-to-end operational responsibility for complex SMR registers without taking up GP partner time.
Unlike traditional locum recruitment agencies that supply variable staff requiring daily GP oversight and sign-offs, Medacy delivers a true managed pharmacy service. Every clinician deployed is a qualified Independent Prescriber from day one, fully compliant with the CPPE Primary Care Education Pathway.
Through a secure VPN connection, Medacy pharmacists access practice clinical systems (EMIS Web, SystmOne, Vision, and Medicus) alongside everyday communication tools (Accurx and Docman). Because our service is delivered remotely, practices overcome physical consulting room deficits immediately.
Crucially, Medacy operates under a Zero-Burden Promise: all clinical oversight, supervision, monthly audit of prescribing decisions, and mentorship are managed internally by Medacy Senior Pharmacists. Practice GP partners are never burdened with supervising our team, allowing surgeries to address their frailty backlogs while safeguarding partner time.
How Do Structured Reviews Support PCN Prescribing Safety Targets?
Structured medication reviews support Primary Care Network prescribing safety targets by systematically identifying high-risk medication combinations before they trigger emergency department attendances.
By deploying dedicated clinical pharmacy capacity across a Primary Care Network, surgeries can implement systematic stratification for their frailty cohorts:
- Targeted Falls Prevention: Identifying patients aged 65 and over taking multiple anticholinergic or sedative medicines, switching them to safer therapeutic alternatives.
- De-escalating Overtreatment: Safely relaxing intensive glycaemic or blood pressure targets in frail elderly populations where the risks of hypoglycaemia or postural hypotension far outweigh preventative cardiovascular gains.
- High-Risk Drug Monitoring: Auditing patients on lithium, methotrexate, and anticoagulants to ensure appropriate blood monitoring intervals and dosing compliance.
- Streamlined Workflow Integration: Handling the complete consultation loop (including issuing prescriptions, updating medical records, and contacting community pharmacies) so no administrative spillover lands on GP desks.
This proactive approach turns frailty management into an auditable clinical pathway that directly supports national quality indicators and local Neighbourhood Health priorities.
Case Study: Driving Measurable Frailty Outcomes in a Welsh Cluster
A targeted frailty project across a five-practice Welsh cluster demonstrates how dedicated, remotely managed clinical pharmacy directly reduces polypharmacy and improves medication safety in high-risk rural cohorts.
The Challenge
The cluster initiated a targeted, two-year frailty project to protect vulnerable patients from medication harm. Practices required a systematic mechanism to address polypharmacy, minimise high anticholinergic burden that precipitates falls, and eliminate inappropriate antipsychotic use among patients living with dementia. With local GP capacity under constant strain, the cluster required specialised support that would not drain GP supervision hours.
The Managed Solution
Medacy deployed a dedicated remote clinical pharmacist across all five surgeries. Working within the practices’ clinical software, the pharmacist delivered targeted, high-intensity reviews for defined high-risk cohorts:
- Patients recorded on the cluster’s frailty register.
- Patients aged over 80 prescribed eight or more distinct medications.
- Individuals diagnosed with dementia who were prescribed antipsychotic therapies.
- Patients aged over 65 taking medicines associated with a high anticholinergic score.
The model deployed structured, collaborative review sessions with local GPs to coordinate joint deprescribing goals while maintaining complete internal clinical governance.
Quantifiable Clinical Impact
The service expanded rapidly, achieving 2,125 clinical interventions in a single month (recorded in January 2026). Key clinical and operational outcomes included:
- 39% Reduction in Antipsychotic Prescribing: Targeted intervention resulted in a 39% reduction in inappropriate antipsychotic prescriptions for dementia patients over an eight-week evaluation window.
- Significant Falls Mitigation: The pharmacist conducted high volumes of Anticholinergic Cognitive Burden assessments (completing 177 in autumn 2025 and 71 in January 2026), systematically removing drugs known to cause drowsiness, dizziness, and fractures.
- Active Deprescribing of Harmful Polypharmacy: Inappropriate and unsafe medicines were safely stopped across the cluster (including stopping 39 unnecessary items in January 2026 and 16 in February 2026).
- GP Workload Relief: During a single month, the remote service delivered 1,762 general medication review activities alongside 136 specialist frailty reviews, returning hundreds of clinical hours back to cluster GPs.
By introducing a structured, remote clinical workflow, the cluster turned a reactive prescribing struggle into a measurable preventative success.
Restoring Clinical Quality to Frailty Management
The Public Accounts Committee’s findings are a clear signal that general practice requires structured, workforce-level intervention to protect frail patients. Relying on overburdened GPs to absorb 30-minute polypharmacy reviews is neither clinically sound nor operationally sustainable.
Medacy’s managed clinical pharmacy service provides the stability, independent prescribing qualifications, and internal governance required to deliver proactive frailty care at scale.
To discover how Medacy can manage your severe frailty registers and Structured Medication Reviews with zero GP supervision, contact us to design a bespoke clinical model for your practice or network.ed
